Target intelligence / Profile preview

novel transcript, antisense to Zinc finger protein 24

Molecular classification
Other
01

Overview

The entry "novel transcript, antisense to ZNF24" (ENSG00000308423) refers to an annotated transcript described as antisense to the protein-coding gene *Zinc finger protein 24* (ZNF24). Unlike ZNF24, which codes for a transcription factor involved in oligodendrocyte myelination and tumor suppression[1][2][5][6], there is no functional, mechanistic, or clinical information available for this antisense transcript in major gene or biomedical databases. It is not recognized as a receptor, enzyme, transporter, therapeutic target, or biomarker. This suggests the entry is either not biologically validated, not of therapeutic interest, or an artifact from transcriptome annotation pipelines. Caveat: - There is extensive literature and data on *ZNF24 (Zinc finger protein 24)* itself[1][2][5][6], but nothing directly supports the therapeutic relevance, clinical use, or clear molecular function of an antisense transcript to ZNF24. - The use of an Ensembl ID in the ENSG00000308xxx range is highly atypical for known, protein-coding, functional targets (e.g., *ZNF24* is ENSG00000172466[5]), further substantiating that this entry may refer to a predicted, low-confidence transcript[5]. Summary: The given target is not a recognized therapeutic target; there is likely a data entry issue or an annotation describing an uncharacterized transcript. All functional and disease information pertains to *ZNF24*, not to this antisense entity[1][2][5][6].

Beyond the preview

Go deeper on novel transcript, antisense to Zinc finger protein 24.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to Zinc finger protein 24.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call